Vincerx Pharma Inc (VINC) Return on Assets ROA from the first quarter of 2025 to first quarter of 2024 and for the year 2025, Average High and Low, Fundamental Ratios from Mar 31 2025 to Mar 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Vincerx Pharma Inc   (VINC)


Vincerx Pharma Inc 's ROA from the first quarter of 2025 to the first quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Vincerx Pharma Inc 's ROA in the first quarter of 2025?
Vincerx Pharma Inc recorded a cumulative net loss of $-23 million during 12 months ending in the first quarter of 2025, resulting in a negative return on assets (ROA) of -184.24%.

However, within the Healthcare sector 916 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2025 quarter, so far to 4728, from total ROA ranking in the fourth quarter of 2024 at 5493.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter
Y / Y Total Assets Change -57.72 % -56.06 % -43.12 % -38.97 % -76.5 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -23 -30 -27 -28 -38
Return On Assets (TTM) -184.24 % -216.51 % -164.38 % -146.27 % -165.27 %
VINC's Total Ranking # 4728 # 5493 # 4811 # 4815 # 4904
Total Assets (TTM) in million 5 8 15 22 11
Seq. Total Assets Change -41.46 % -46.44 % -30.57 % 94.23 % -39.16 %
Seq. Net Income Change - - - - -

VINC's 5 Years Annual ROA >> Back to VINC Management Effectiveness >> Compare VINC ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 444
Sector # 917
Overall # 4658

Return On Assets Statistics
High Average Low
0.02 %
-87.39 %
-216.51 %
(Dec 31 2020)   (Dec 31 2024)





Financial Statements
Vincerx Pharma Inc 's Assets $ 5 million VINC's Balance sheet
Vincerx Pharma Inc 's Income $ -5 million Quarterly VINC's Income Statement
VINC's Income by Division See VINC's Income by Division



Annual Return On Assets (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021		 (Dec 31 2020)
FY 2020
Y / Y Total Assets Change -56.06 % -69.27 % -49.62 % -8.7 % -
Total Assets in million 8 18 59 118 129
Y / Y Net Income Change - - - - -
Net Income in million -30 -40 -65 -39 -17
Annual Return On Assets -375.69 % -220.44 % -110.26 % -33.4 % -12.9 %

VINC's 5 Years Annual ROA >> Back to VINC Management Effectiveness >> Compare VINC ROA to its Competitors



More Return On Assets Ratios
VINC's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
VINC's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for VINC's Competitors
Subscribers only: Roa for Vincerx Pharma Inc 's Suppliers
Subscribers only: Return On Assets for VINC's Customers

You may also want to know
VINC's Roi VINC's Inventory Turnover Ratio VINC's Growth Rates VINC's Dividend Comparisons
VINC's Profitability Ratios VINC's Asset Turnover Ratio VINC's Dividend Growth
VINC's Roe VINC's Valuation Ratios VINC's Financial Strength Ratios VINC's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 31 2025, within Healthcare Sector ROA

Date modified: 2026-08-29T17:41:27+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.